Current Drug Therapy

Professor Hassan Y. Aboul-Enein is a Professor Emeritus at the Pharmaceutical and Medicinal Chemistry Department , National Research Center in Cairo ,Egypt and the Chemistry Department. Professor Aboul-Enein is the author and co-author of over 1000 refereed published articles, 90 book chapters and more than 400 conference presentations. He is also authored and edited 8 books in the field of analytical chemistry. He is on the Editorial Board of 22 journals and the Associate Editor of Current Drug Therapy (Bentham Science Publishers) since 2005.

Dr. Jia-You Fang is a Professor in the Graduate Institute of Natural Products at Chang Gung University in Taiwan. In addition, he is an Adjunct Professor in the Graduate Institute of Health Industrial Technology, Chang Gung University of Science and Technology and Department of Anesthesiology, Chang Gung Memorial Hospital. Over the past 25 years, he and his team have made outstanding contributions to the understanding of drug delivery, pharmaceutics, pharmacokinetics, nanomedicine, and cosmetology. His contributions add up to 228 peer-review articles, more than 5064 citations and H index of 39 (Scopus).

Prof. Imran Ali, PhD, FRSC (UK) is a full Professor at Jamia Millia Islamia Central University, India. He has 25 years of experience in the research, discovery and development of chiral and anti cancer drugs development. He has more than 350 publications including five books and two patents, with total citations more than 10000, 41 h-index and 136 i10-index. He member of RSC, UK and ACS, USA. He has been visiting Professor at KSU Riyadh, SQU, Muscat Oman, UTM, Johor, Malaysia. He is on Editorial Board Member of 10 National and International Journals. He is reviewers of more than 50 National and International Journals.

Dr. Massimilano Filosto has obtained his PhD in Neurosciences at University of Verona after a postdoctoral research fellowship at the Department of Neurology, Columbia University, New York, USA. He is a member of the Treat- NMD Neuromuscular Network. His main interests is in the field of Neuroscience are muscle, nerve and motor neuron diseases. His work focuses on metabolic myopathies,genotype/phenotyperelations,epigenetic and pathological findings in mitochondrial diseases and muscle glycogenoses. He is full Individual Member of the European Academy of Neurology and participates to expert panels in neuromuscular diseases, peripheral neuropathies and motor neuron diseases.

Dr. Khalid Aftab, Ph.D. male, Pharmacologist, graduated from department of Pharmacology, Faculty of Pharmacy University of Karachi, Pakistan in 1995. He worked for Pharmaceuticals industry as Quality Control & Quality Assurance professional and was actively involved in Research & Development of Pharmaceutical preparations. He is the Only Pakistani Pharmacologist who has got membership of American College of Clinical Pharmacology. He has published more than 50 papers in scientific journals of international repute and presented many lectures & poster presentations throughout the world. In recent year, he focused on the Biodiversity & Pharmacological activities of Marine organisms and got some important success.

Prof.Dr. Esra KÜPELİ AKKOL was born in Turkey. She got her Bachelor of Science degree in Faculty of Pharmacy, Gazi University, Turkey and got her Ph.D. degree in Pharmacognosy Department from the University of Gazi. She is currently Professor in the Gazi University, Faculty of Pharmacy, Department of Pharmacognosy. She served in many capacities in her field including service on several editorial boards and numerous review committees for journals such as Journal of Ethnopharmacology, Journal of Pharmacy Sciences, The Internet Journal of Herbal and Plant Medicine, International Journal of Genuine Traditional Medicine, Advances in Pharmacological Sciences, Evidence Based Complementary Alternative Medicine and The Open Pain Journal. She has conducted 49 projects and 13 thesis in Gazi University. She has 170 published articles in SCI International Journals, 13 articles in National Journals and 10 chapters in International books.

Prof. Israel Amirav is a pediatric pulmonologist and internationally renowned leader in aerosol therapy for infants and young children. He graduated from the Tel Aviv University Medical School in 1981 and then from 1990-94 undertook a Pediatric Pulmonary fellowship at Children’s Hospital of Philadelphia. After completing his training in the USA, he returned to Israel where he headed the pediatric pulmonology service for in the Northern part of Israel for the next 25 years. In 2013 he moved to the University of Alberta in Edmonton, Canada where he is currently Associate Professor and Educational Program Director. In all, he has published >90 studies, mainly related to aerosol therapy but also in areas such as asthma and PCD.

Prof. Stefano Angioni is Associate Professor in Gynecology and Obstetrics at the University of Cagliari, Italy. He obtained a Doctorate (Ph.D.) in Biology of Human and Animal Reproduction from the University of Bari (Italy) and actually is mainly involved in the surgical and pharmacological management of chronic pelvic pain and infertility. He is the President of the University School of Midwifery at the University of Cagliari. Prof. Angioni authored more than 150 manuscripts and co-edited several scientific books.

Dr. Toshiharu Azma is the Division Director of Perioperative Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Japan. He also serves as the head of the Department of Anesthesiology & Pain Medicine in the hospital. Previously, he served as the associate professor of the Faculty of Medicine, Saitama Medical University, and is currently the visiting associate professor of the University Hospital. During his career at Hiroshima University, he obtained Ph.D. of medicine from the Graduate School of Medical and Pharmaceutical Sciences in 1996. His research interests include: interventional pain medicine, perioperative management and diagnosis for hemostasis, etc.

Prof. Maciej Banach was an Undersecretary of State at the Ministry of Science and Higher Education of the Republic of Poland (2010-2012). He is a President of Polish Mother's Memorial Hospital - Research Institute, full Professor of Cardiology and Head of Department of Hypertension at the Medical University of Lodz, Poland. He is member of the Executive Committee of European Atherosclerosis Society (EAS), Founder and Head of the Polish Lipid Association (PoLA), and the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. He is a Visiting Professor of University of Alabama at Birmingham (UAB) and University of Medicine and Pharmacy Victor Babes in Timisoara, Romania.

Dr. Francesco Bifari obtained his Ph.D. degree (2009) from the Graduate School of Translational Biomedicine, University of Verona, Verona, Italy. Since March 2016, Dr. Bifari is Principal Investigator in the Laboratory of Cell Metabolism and Regenerative Medicine, Department of Medical Biotechnology and Translational Medicine, at University of Milan, Milan, Italy. His research interests are focused on understanding the role of newly discovered meningeal-resident adult neural stem cells in brain plasticity and regenerative medicine. Dr. Bifari, as an author/co-author, has published more than 30 articles in various journals, having over 1,530 total citations.

Francesco Borgia is Assistant Professor of Dermatology and Venereology at University of Messina (Italy). His research interests include photodermatology, with particular attention to photodynamic therapy in Non Melanoma Skin Cancer and inflammatory diseases, and drug-related skin adverse reactions. He is author of more than 60 scientific publications on international journals and chapters in books in the field of dermatology and general medicine.

Dr Chattopadhyay received PhD from Jadavpur University in 1989 and Post-Doc from London Hospital Medical College and Statens Serum Institute. He joined ICMR in 1993 and served as ‘Scientist B’ to ‘F’ at ICMR-Virus Unit, Kolkata. In 2016 he joined RMRC Belagavi as Director (Scientist G). His field of study includes Ethnomedicinal Drug discovery, Microbiology and Virology. Establishing personal relationship with tribal communities he unveils their health care wisdom through scientific validation. He has 7-patents, 54-popular articles and 126 papers in peer-reviewed prestigious Journals with h-index 28 and 2684 citation, serving as Editorial Board Member and Reviewers of prestigious Journals, Examiner, PhD Guide, visiting Faculty and recipient of several awards. Dr Chattopadhyay implemented several National Task Force Projects, and is the Member of Review and Approval Committee of Govt Funding Agencies.

Dr. Cui obtained a doctorate (Ph.D.) in Molecular Immunological Pharmacology from Peking Union Medical College. He has nearly 15 years of experience in the research, drug discovery development of medications aimed to treat cancer, cardiovascular, fibrotic diseases. Currently Dr. Cui is a professor in the Institute Materia Medica, Peking Union Medical College. He has published more than 30 scientific publications and is a named inventor of 8 issued patents.

Dr. Dai obtained his Ph.D degree in Peking Union Medical College in China. He is now an assistant professor in Department of Radiation Oncology at University of Florida. Dr. Dai have been working in the field of cancer biology, radiation therapy and experimental therapeutics for over 17 years. His research is about understanding cancer progression and evaluating therapeutic effects of novel molecular targeting agents. Dr. Dai has accomplished many peer-reviewed publications, including research articles, reviews, book chapters and patents. He also serves as an ad hoc reviewer for over 20 international journals in biomedical science.

Dr. Domenico De Berardis, M.D., Ph.D., works as Psychiatrist and Psychotherapist in the "real world" clinical practice at the NHS Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital “G. Mazzini”, ASL 4 Teramo, Italy. Dr. De Berardis collaborates independently with the Institute of Psychiatry of University of Chieti-Pescara, Italy (concerning research projects and teaching). His research interests and fields of expertise include the following: clinical psychiatry, clinical psychopharmacology, clozapine, newer antidepressants, long-acting antipsychotics, alexithymia, emotions, functional somatic symptoms, anxiety disorders, mood disorders, schizophrenia, functional magnetic resonance, obsessive-compulsive disorder, etc. He has published over 120 peer-reviewed articles, and several book chapters.

Dr. Ding is an Associate Professor with tenure at the Department of Pathology, and a Member of the Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center. He obtained his PhD in Medical Sciences from Lund University, Sweden, and trained as a postdoctoral fellow at the Molecular Pharmacology section, Mayo Clinic and Foundation, Rochester Minnesota. Dr. Ding has been actively engaged in exploring drug action mechanisms over the last 20 years, with effort concentrated on anticancer actions of n-3 polyunsaturated fatty acids and metal binding compounds.

Obtained a doctorate (MD) from the Hebrew University, Hadassah School of Medicine, Jerusalem, Israel. Trained both in Israel and the John's Hopkins Hospital, Baltimore, USA, in Pediatric and adults neurology. Board certified in Pediatrics, Pediatric, Developmental and Adult Neurology. Former chairman of the section of Neurology and Neurosurgery at the Tel-Aviv University , Israeli Society of Pediatric Neurology and Israeli Neurological Association. At present, Chairman of Israeli neurophysiological society and professor (Emeritus) at the Tel-Aviv University . Member of more than 20 international scientific societies,5 editorial Boards and senior/ associated author of more than 200 peer-review publications , 6 book chapters and 1 book editor.

Dr Vandita Kakkar is an Assistant Professor in the Department of Pharmaceutics, U.I.P.S, Panjab University, Chandigarh and has a research experience of more than 8 years. Her area of research lies in: Bioavailability enhancement of phytopharmaceuticals using nanoparticle technology via oral and topical routes; Scale up of the nanoparticle production from lab scale to pilot stage; Combatting antimicrobial resistance, & developing targeted delivery systems for cancer treatment. She has to her credit 36 international/national research papers and review articles with h-index 12 and 1006 citations; 6 book chapters in international books and 2 national patent applications.

Dr. Varun Khurana graduated with a Ph.D. in Pharmaceutical Sciences and Chemistry from reputed University of Missouri Kansas City, Kansas City, MO. Currently, he is working as a Formulation Scientist at Nevakar LLC, Bridgewater, NJ, a specialty pharmaceutical company that develops and commercializes innovative products in injectable and ophthalmic space. Prior to Nevakar, he was employed as a Formulation Scientist at Insys Therapeutics Inc, Chandler, AZ. His research has been published in several peer-reviewed journals and books in the field of pharmaceutical sciences.

Dr hab. Aleksandra Kładna is the Professor of Pomeranian Medical University in Szczecin. She optained Ph.D. of medicine in 1986 and Habilitation in 1996. She is a medical specialist in Dermatology with Venerology and in Palliative medicine. Dr hab. Kładna has over 30 years of experience of being a lecturer, a clinicist and a researcher. She is a member of many scientific societes. Her research interests include: the role of oxygen free radical in human diseases and the usage of novel compounds antioxidaton properties, public health, medical empathy. Dr hab. Kładna is an author/co-author of 138 scientific publications and one book.

Dr. Menaa (PhD, MBA, MD candidate) is an internationally inter- and multi-disciplinary professional with holistic concept of Medicine. More than 10 years experiences in academic institutions (e.g. France, USA, Germany, Brazil) and industrial sectors (e.g. Guerbet SA, SANOFI, Fluorotronics Inc.). He is an independent consulting expert, researcher and Chief Editor of Journal of Nanomedicine and Nanotechnology (http://www.omicsonline.org/editorialboard-nanomedicine-nanotechnology-open-access.php). He is also member of various scientific committees, boards and associations, and organized the “Target Meeting´s 1st World Nanomedicine and Nanobiotechnology Online Conference” (http://www.targetmeeting.com; 2013). He has contributed to over 100 scientific articles, 200 international events, and is the recipient of various recognitions.

Prof. (Dr.) Pradyumna Mishra is currently Deputy Director of the ICMR-National Institute for Research in Environmental Health, Bhopal, India. He is a recipient of prestigious Fulbright-Nehru Fellowship (USA) and is a Visiting Faculty Associate to Weizmann Institute of Science, Israel and Osaka University, Japan. Recently, he was nominated as one of the Foreign Affiliate Members in Foundation for Polish Science, Warsaw, Poland. He is Associate Editor-in-Chief of Frontiers in Genetics and serves on the editorial boards of several scientific journals and committees as well as technical advisory bodies. He is primarily involved in inter-disciplinary research with equal emphasis laid on molecular immunology and translational medicine. Dr. Mishra’s track record of academic accomplishments is backed up by more than 125 primary peer-reviewed publications (Citations>2400; Impact Factor>335.0; h-index=30). He has several collaborative research projects with leading academic investigators in established centres of excellence both in India and abroad.

Dr. Monica Mita is a medical oncologist in Los Angeles, California and is affiliated with multiple hospitals in the region, including Cedars-Sinai Medical Center and UCLA Medical Center Santa Monica. She received her medical degree from Carol Davila University of Medicine and Pharmacy and has been in practice for more than 20 years. She is currently co-director of the Experimental Therapeutics Program at the Samuel Oschin Comprehensive Cancer Institute. Her main research are on phase I clinical trials in oncology, novel drugs, and targeted therapies, with more than 50 peer reviewed articles published.

Stuart Montgomery is Emeritus Professor of Psychiatry at Imperial College London. He was President of the European College of Neuropsychopharmacology (ECNP) from 1992 to 1995. Professor Montgomery is a very well-known and highly cited researcher in depression, anxiety disorders and schizophrenia. His rating scale in depression, the MADRS, is regarded as the most sensitive instrument and is widely used in placebo-controlled studies. He was a founding editor of European Neuropsychopharmacology and has edited International Clinical Psychopharmacology for 25 years.

Dr. Giuseppe Murdaca, M.D. (1993), Ph.D. (2003), is currently Associate Professor of Internal Medicine, in the Department of Internal Medicine and Medical Specialties, at University of Genova, Italy. His research interests involve Immunodeficiency, Autoimmunity, Neuro-endocrino-immunology, Pharmacogenomics, and Vaccine and autoimmune diseases. Dr. Murdaca has authored/co-authored over 90 article publications in various journals, having a significant number of total citations, i.e. more than 1,870. He has membership in Italian Society of Immunology, Clinical Immunology and Allergy, Italian Society of Internal Medicine, and Italian Society of Experimental Biology. Furthermore, he is Editor-in-Chief of several other journals, i.e. Edorium Journal of Medicine, Autoimmune Diseases and Therapeutic Approaches: Open Access, Journal of Immunization, etc.

Sibel A. Ozkan is presently working as a Full Professor of Analytical Chemistry at Ankara University, Faculty of Pharmacy. She has been involved in several analytical chemistry projects related to electroanalytical chemistry and separation techniques on drug active compounds and DNA–Drug interactions. Her research interests included analysis of pharmaceuticals with using different analytical techniques. She has published more than 200 original and review papers and two scientific books from HNB Publishing, (2012) and Springer (2015). She is the Editor and Editorial Board Member of the many journals.

Dr. Paliwal received his doctorate from Dr. H. S. Gour University, Sagar, India. Presently, he is working in the Department of Pharmacy, Indira Gandhi National Tribal University, Amrkantak, India. He has nearly 12 year of research experience in nanomedicine, controlled drug delivery and cancer drug targeting. He has contributed as author/co-author in 35 international publications, 14 book chapters, 2 guest edited issues and 01 book. Dr. Paliwal is recipient of many national and international awards including MP young scientist award 2007, Rudolf Cimdins award 2009 and career award for young pharmacy teachers, 2013 to his credit. Additionally, he is an active reviewer of more than 30 international journals and grant funding agencies.

Dr. Carolina Panis, MD, PhD (in biochemistry), post-graduated in Pathology from the Londrina State University (UEL), Brazil, and Instituto Nacional do Câncer (INCA), Brazil. Dr. Panis currently works as a professor and researcher at the State University of West Paraná (UNIOESTE), Brazil, in projects related to genomics, proteomics and inflammatory aspects of human breast cancer and chronic diseases. Dr. Panis, as an author/co-author, has published more than 70 articles in various journals, having over 935 total citations.

Dr. Pomara is the Director of the Geriatric Psychiatry Division at Nathan S. Kline Institute (NKI) and a Professor in the Department of Psychiatry and Pathology at the New York University School of Medicine. He has been involved in research pertaining to Alzheimer’s disease and Geriatric Psychopharmacology for more than 30 years. Dr. Pomara has more than 140 authored publications, 15 chapters/books, and 80 collaborative publications. He has received numerous grants from the NIH and presented at various national and international scientific meetings. He is a member of both the American and European College of Neuropsychopharmacology in addition to many other scientific organizations.

Dr. Arun Ravindran is Full Professor and Director of Global Mental Health and the Office of Fellowship Training for the Department of Psychiatry, University of Toronto. He is cross-appointed as Graduate Faculty in the Institute of Medical Sciences, and is also a Senior Scientist in the Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health. Dr. Ravindran’s clinical and research interest is in the area of mood and anxiety disorders. He has held or currently holds grant funding from national and international agencies. He is also actively involved in capacity-building and humanitarian global mental health projects .

Prof. Rizzo is Associate Professor of Internal Medicine at the School of Medicine, University of Palermo, Italy as well as Associate Professor of Internal Medicine at the School of Medicine, University of South Carolina, USA. Prof. Rizzo sits on the editorial board of 9 international journals with Impact Factor. He has been the recipient of national and international fellowships and awards, and acted as reviewer for 100+ scientific international journals. The research work of Dr. Rizzo combines translational research (focus on the effects and mechanisms of action of lipid-­‐lowering and anti-­‐diabetic agents) and basic research (focus on novel cardiovascular risk factors), with 200+ scientific publications with Impact Factor (total Impact Factor: >700. H-­‐Index: 42).

Dr. Emmanuel A. Theodorakis obtained Ph.D. from Texas A & M University. He has been serving as a Professor of Chemistry and Teddy G. Traylor Scholar at University of California, San Diego. His skills and expertise are in Synthesis, Organic Synthesis, Synthetic Organic Chemistry, Medicinal and Pharmaceutical Chemistry, Natural Product Chemistry, Multistep Synthesis, Drug Synthesis and Synthetic Methodology. He has contributed more than 180 publications, having citations around 5,467. He has also been recognized with awards and honors such as Teddy G. Traylor Scholar Award, UCSD, Hellman Faculty Fellowship Award, Editorial board member: Current Chemical Biology and etc.

Chun-Wei Tung is an associate professor in Graduate Institute of Data Science, Taipei Medical University, Taiwan. He is also an adjunct assistant research fellow in National Environmental Health Research Center, NHRI, Taiwan. His research interests include bioinformatics, immunoinformatics and toxicoinformatics. He is also a member of IAPR TC-20 (Technical Committee on Pattern Recognition in Bioinformatics)

Bengi USLU is currently a Professor in Ankara University Faculty of Pharmacy, Department of Analytical Chemistry, in Turkey. Her areas of interest are electrochemistry, biosensors, nanosensors biotechnology, liquid chromatography, drug analysis, biological sample analysis, redox mechanisms of drugs, spectrophotometry, validation, separation techniques, method development, research and development. She has published as author or co-author of more than 150 scientific articles and publications. She received in 2008, Ankara University Scientific Support Award, in 2014 Ankara University Scientific Award and in 2015 Academy of Pharmacy Science Award of Turkish Pharmaceutical Association. She has been Co-editor of special issues and reviewer of many scientific journals. She has many chapters in books and translated books.

Dr Vree worked as chemist, pharmacologist and faculty member in the departments of Clinical Pharmacy (laboratory) and Anesthesiology of the Radboud University, Nijmegen, The Netherlands. Dr. Vree has authored and co-authored 600 publications dealing with the chemical analysis of drugs and its metabolites in body samples of patients of a wide variety of medical disciplines in the University Hospital. Research activities included chemical analysis of drugs, metabolites and conjugates, pharmacokinetics and bioequivalency.

Dr. Fan Wang obtained her Ph.D. from China Institute of Atomic Energy, Beijing, China. She is currently a full professor and director of Medical Isotopes Research Center, Peking University, China. She has published more than 80 scientific publications and is a named inventor of 8 issued Chinese patents. Dr. Wang serves as the Associate Editor of Biophysics Reports, editorial board member of Bioconjugate Chemistry and Nuclear Science & Techniques.

Jeffrey Weitz is Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University, Canada and Executive Director of the Thrombosis and Atherosclerosis Research Institute in Hamilton, Canada. He holds the Canada Research Chair in Thrombosis and the Heart and Stroke Foundation J. Fraser Mustard Chair in Cardiovascular Research. His clinical practice focuses on patients with thrombosis and his research spans the spectrum of basic, translational and clinical investigation into the pathogenesis, diagnosis and treatment of thrombotic disorders. He has published over 450 peer-reviewed papers and 60 book chapters on thrombosis and fibrinolysis.

Dr. Dharmendra Kumar Yadav obtained a Ph.D. in Biomedical Sciences from CSIR- Central Institute of Medicinal and Aromatic Plants, Lucknow, India in 2013. Currently, he is working as a Research Professor and Principal Investigator of NRF project (Korea) at College of Pharmacy at Gachon University, Korea. His research interests included Molecular modeling & Drug Design, and Molecular simulation of Plasma Medicine. He has published more than 45 original and review papers and three scientific books chapter one US patent. He is the Editor and Editorial Board Member of the many journals.

Dr. Yanmin Zhang is a full professor of School of Pharmacy, Health Science Center, Xi'an Jiaotong University of China. Yanmin Zhang received his B.S. in chemistry and Ph.D. in Pharmacy. He is currently the director of molecular pharmacology program. He has holden more than 15 national projects, published 117 papers including Pharmacol Therapeut, Advanced Science, Semin Cancer Bio, Cell Death Dis, Sci Rep, J Cell Mol Med, Cancer Lett, et al. and holden 26 patents.

Peter CM van de Kerkhof is Chairman of the department of dermatology, Radboud University Nijmegen Medical Centre. He has been working for more than 35 years on the pathogenesis and treatment of psoriasis. He has published more than 600 publications in peer reviewed internationally journals and acted as promotor or copromotor in 69 dissertations. He has been president of several international societies, including the European Society of Dermatological Research and the European Dermatology Forum. He is associate editor or member of the editorial board of 11 international Journals. He is past-president of the European Society of Dermatological Research, European Dermatology Forum and the International Psoriasis council.

After full degree in Medicine in 2007, I obtained in 2013 the Board in Internal Medicine at the Cagliari University, Italy.  I’ve been working at the Department of Internal medicine, Allergy and Clinical Immunology. I focused my research interests on three main fields: autoimmunity, primary immunodeficiencies and rare diseases associated with dysregulation of immunity. In 2013 I have been elected as the Junior Representative in Biologicals Interest Group, at European Academy of Allergy and Clinical Immunology. Currently, I’m Associate Professor at University of Cagliari.

Dr Vandita Kakkar is an Assistant Professor in the Department of Pharmaceutics, U.I.P.S, Panjab University, Chandigarh and has a research experience of more than 8 years. Her area of research lies in: Bioavailability enhancement of phytopharmaceuticals using nanoparticle technology via oral and topical routes; Scale up of the nanoparticle production from lab scale to pilot stage; Combatting antimicrobial resistance, & developing targeted delivery systems for cancer treatment. She has to her credit 36 international/national research papers and review articles with h-index 12 and 1006 citations; 6 book chapters in international books and 2 national patent applications.

Dr. Wei Wang is an associate professor at Jiangsu Institute of Parasitic Diseases and the Key Laboratory on Technology for Parasitic Disease Prevention and Control, National Health Commission of China. His research interests focus on drug development and screening for neglected tropical diseases (NTDs) and drug resistance. Dr. Wei Wang has published over 100 scientific papers in international peer-reviewed journals and book chapters.

Dr. Maria Jesus Alvarez Cubero graduated in Biology and later obtained her PhD. She has been collaborating in teaching and scientific tasks (as it is proved with the 48 publications in indexed databases in the forensic genetic, biomedicine and oncology field, most of the half in Q1 standing). She has expertise in research training and teaching (which is recognized by national agencies such as ANECA).